Wednesday - April 24, 2019
PhRMA Decries Damaging Foreign Practices in Special 301 Filing
February 08, 2019
WASHINGTON, Feb. 8 -- The Pharmaceutical Research and Manufacturers of America issued the following news release:

The Pharmaceutical Research and Manufacturers of America (PhRMA) today urged the Office of the United States Trade Representative (USTR) to take immediate action to address serious and growing market access and intellectual property barriers in top overseas markets.

In its submission for USTR's annual Special 301 Report, PhRMA called on the Trump administrat . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products